ArticleJournal of ginseng research2025
Ginsenoside Rh2 alleviates inflammatory response and enhances motor function recovery in spinal cord injury mice via the ROS/MAPK14 signaling pathway.
Article in Journal of ginseng research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- The roles of ginseng and ginsenosides for immune regulation: Relation to immunometabolic responses.Journal of ginseng research · 2026Review
- Ginsenosides Rh2 and Rg3 in first-line combination therapy: Prospects for rapid clinical translation in drug-resistant triple-negative breast cancer.Journal of ginseng research · 2026Review
- Ginsenosides fromJournal of ginseng research · 2026Review
- Review
- Ginsenoside Rg5 Targets PRDX1 to Disrupt Redox Homeostasis and Induce Mitochondria-Dependent Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells.Molecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Inhibiting inflammation in nervous system is a vital part of treating for spinal cord injury (SCI). Compounds originating from plants can decrease the damage in the spinal cord for recovering the function of nerve and interrupting the inflammatory reaction. 20(S)-Ginsenoside Rh2 (G-Rh2) from Panax ginseng is an anti-inflammatory property inhibiting the expression of MAPK14 protein by enabling the MAPK pathway. Therefore, this research explored the anti-inflammatory effects of G-Rh2 on SCI using cellular and animal models. Methods: To explore G-Rh2's anti-inflammatory potential in SCI, we employed bioinformatics analysis to anticipate target proteins and signaling pathways associated with G-Rh2 and SCI. We utilized BV2 microglia cells to model inflammation induced by lipopolysaccharide (LPS), and a modified Allen's technique in a mouse SCI model. Our investigation utilized a range of methodologies including quantitative real-time polymerase chain reaction (qRT-PCR), Enzyme-Linked Immunosorbent Assay (ELISA), Immunofluorescence (IF) and Western Blot (WB). Results: Bioinformatics analysis and molecular docking identified MAPK14 as a key target of G-Rh2. In BV2 cells experiments, G-Rh2 reduced the expression and generation of inflammatory factors, reactive oxygen species (ROS), and transcription factors involved in the MAPK signaling pathway. G-Rh2 showed a decrease in inflammatory reaction and improvements in motor function in the mouse model using the modified Allen's approach for SCI. Conclusion: G-Rh2 mitigates inflammatory responses and enhances motor function recovery in mice with SCI via the ROS/MAPK14 signaling pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.